Nov 17, 2022 / 09:10AM GMT
Unidentified Participant
I think it's time. Yes, good morning, everyone, and thank you for attending our London Healthcare Conference. Today we have Ms. Abbey Jenkins, President and CEO of Gamida Cell to share her insights on the company. Welcome.
Abbey Jenkins - Gamida Cell Ltd. - President & CEO
Thank you. So I'm excited to be here today to share an update on Gamida Cell's progress. We're committed to developing potentially curative therapies for people with cancer and other serious diseases.
Before we get started, please take a moment to review this disclosure. During this presentation, I'll be making a number of forward-looking statements. Please refer to our recent SEC filing from November 14 for more information on the company, including our risk factors.
So I joined Gamida Cell just about two months ago, on 19th we'll mark 60 days on the job. And I was incredibly excited to Gamida Cell for three reasons: one, the mission; two, the science; and three, the team.
The mission is incredibly inspiring. I've been in this business for
Gamida Cell Ltd at Jefferies London Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot